PTCT PTC Therapeutics, Inc. Tezkor likvidlik koeffitsiyenti

PTC Therapeutics Corp (PTCT) korporativ emblemasi va logotipi

PTC Therapeutics, Inc. (PTCT) ekotizimi kam uchraydigan genetik patologiyalarga qarshi kurashishga e'tibor qaratgan holda, hayotiy muhim qo'llab-quvvatlash muhitini yaratadi. Yakuniy tezkor koeffitsient kompaniyaning to'lov qobiliyatini namoyish etadi va joriy daraja 3.23 atrofida shakllangan. Ushbu moliyaviy barqarorlik dori vositalarini yetkazib berishning uzluksiz global kanallari, Translarna va Upstaza preparatlarining tijorat muvaffaqiyati hamda sezilarli naqd pul rezervlari bilan mustahkamlangan.

PTCT: PTC Therapeutics Corp Oraliq qoplash koeffitsiyenti 04.07.2022 - 29.10.2026

PTC Therapeutics, Inc. kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Narx grafigi PTC Therapeutics Corp|PTCT - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi PTC Therapeutics Corp|PTCT - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya uchun buxgalteriya qiymati PTC Therapeutics|PTCT - Kompaniyaning buxgalteriya qiymati|Bozor qiymatining balans qiymatiga nisbati ptcbio.com|PTCT - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati PTC Therapeutics, Inc.|PTCT - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati PTC Therapeutics|PTCT - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati PTC Therapeutics Corp|PTCT - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi PTC Therapeutics|Tezkor likvidlik ptcbio.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
PTCT - Kompaniyaning sof foydasi
Kompaniyaning dastlabki tahlili:PTC Therapeutics, Inc.
PTC Therapeutics Inc yetakchi tovari

Kamyob kasalliklar dori vositalari segmentidagi yuqori kirish to'siqlari PTC Therapeutics, Inc. (PTCT) kompaniyasiga barqaror marjalar va moliyaviy avtonomiyani ta'minlaydi. GURU.Markets platformasidagi joriy likvidlikning tarixiy ko'rinishini tahlil qilib, investor kompaniyaning qisqa muddatli majburiyatlarini faqat naqd pul va debitorlik qarzlari hisobiga, zaxiralarni hisobga olmagan holda qoplash qobiliyatini ko'rishi mumkin. Ushbu konservativ yondashuv yuqori to'lov qobiliyatini va biznesning kutilmagan bozor zarbalariga chidamliligini tasdiqlaydi.

PTC Therapeutics, Inc. kimlar bilan raqobatlashadi

Jazz Pharma (JAZZ) - Tezkor likvidlik|Tezkor likvidlik ko‘rsatkichi Cytokinetics Corp|SRRK (Scholar Rock) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti centessa.com|Tezkor likvidlik ko‘rsatkichi DYN (Dyne Therapeutics)|EWTX (Edgewise Therapeutics Inc) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Rapport Pharma RAPP|ALMS: Shoshilinch likvidlik koeffitsiyenti|Zevra Therapeutics - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik contineum-tx.com|LRMR (Larimar Therapeutics, Inc.) - Tezkor likvidlik ko‘rsatkichi|Capricor Therapeutics, Inc. (CAPR) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik Entrada|PTHS: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik MediciNova, Inc. (MNOV)|SER - Shoshilinch likvidlik|Tezkor likvidlik BioXcel Therapeutics, Inc. BTAI|ProMIS Neurosciences Inc. - Tezkor likvidlik|APUS - Tezkor likvidlik|Shoshilinch likvidlik AEON Biopharma|NLSP: Tezkor likvidlik koeffitsiyenti|Kritik likvidlik Bionomics BNOX|Tezkor likvidlik ko‘rsatkichi HUGE|Shoshilinch likvidlik Reata Pharmaceuticals Inc RETA